BDBM85154 2,3,4,5-Tetrahydro-3-(1H-indazole-3-ylmethyl)-N-(4-methoxyphenyl)-N-(1-methylethyl)-2,4-dioxo-5-phenyl-1H-1,5-benzodiazepine-1-acetamide::CCK-A Agonist 1::GW 5823::GW-5823::N-Isopropyl-N-(4-methoxyphenyl)-3-(1H-indazol-3-ylmethyl)-5-phenyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-acetamide
SMILES COc1ccc(N(C(=O)CN2C(=O)C(Cc3n[nH]c4ccccc34)C(=O)N(c3ccccc3)c3ccccc32)C(C)C)cc1
InChI Key InChIKey=LGYKPDHARJMLQN-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 85154
TargetCholecystokinin receptor type A(Human)
Glaxo Wellcome Research and Development
Curated by ChEMBL
Glaxo Wellcome Research and Development
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Binding affinity against human Cholecystokinin type A receptor by displacement of [125I]CCK-8More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Glaxo Wellcome Research and Development
Curated by ChEMBL
Glaxo Wellcome Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Binding affinity against human Cholecystokinin type B receptor by displacement of [125I]CCK-8More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Human)
Glaxo Wellcome Research and Development
Curated by ChEMBL
Glaxo Wellcome Research and Development
Curated by ChEMBL
